4,4',4''-methanetriyl-tri-pyrocatechol | 60670-04-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: 4,4',4''-methanetriyl-tri-pyrocatechol
• 英文别名: Tris-(3,4-dihydroxy-phenyl)-methan；4,4',4''-Methantriyl-tri-brenzcatechin；tris-(3,4-dihydroxybenzyl)methane；4-[Bis(3,4-dihydroxyphenyl)methyl]benzene-1,2-diol
• CAS: 60670-04-4
• 化学式: C₁₉H₁₆O₆
• 分子量: 340.332
• InChiKey: ZCTXBQCYEMTZIT-UHFFFAOYSA-N

物化性质

• 熔点：
  249 °C
• 沸点：
  661.0±50.0 °C(Predicted)
• 密度：
  1.524±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  121
• 氢给体数：
  6
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  四溴化碳 、 邻苯二酚 在 zinc(II) chloride 作用下， 生成 4,4',4''-methanetriyl-tri-pyrocatechol
  参考文献：
  名称：

  Polyhydroxy leuco derivatives of triphenylmethane and processes for their production

  摘要：

  公开号：

  US02116827A1

文献信息

• Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
  申请人：Snow D. Alan

  公开号：US20070225362A1

  公开（公告）日：2007-09-27

  Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, AA/SAA amyloidosis, such as observed in systemic AA amyloidosis and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

  双羟基和三羟基芳基化合物及其甲氧基二氧杂环化物和药学上可接受的酯类，它们的合成，含有它们的制药组合物，以及它们在治疗淀粉样疾病，特别是阿尔茨海默病中观察到的Aβ淀粉样变性，IAPP淀粉样变性，例如在2型糖尿病中观察到的AA / SAA淀粉样变性，以及突触蛋白病，例如在帕金森病中观察到的应用，以及用于制造这种治疗药物。
• Compounds, compositions and methods for the treatment of synucleinopathies
  申请人：Esposito Luke

  公开号：US20070276034A1

  公开（公告）日：2007-11-29

  Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as Parkinson's disease, and the manufacture of medicaments for such treatment.

  双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药学上可接受的酯，它们的合成，含有它们的制药组合物，以及它们在治疗突触核病，如帕金森病中的应用和制造用于这种治疗的药物。
• COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
  申请人：Snow Alan D.

  公开号：US20090069432A1

  公开（公告）日：2009-03-12

  Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

  双-和三-二羟基芳基化合物及其二氧化甲基类似物和药学上可接受的酯，它们的合成，含有它们的制药组合物，以及它们在治疗淀粉样疾病中的应用，尤其是Aβ淀粉样蛋白病，如阿尔茨海默病，IAPP淀粉样蛋白病，如2型糖尿病，以及突触核病，如帕金森病，和用于制造这种治疗药物。
• Compounds, compositions and methods for the treatment of inflammatory diseases
  申请人：Sanders J. Virginia

  公开号：US20070208087A1

  公开（公告）日：2007-09-06

  The use of a composition comprising a compound: where R is a C 1 -C 10 alkylene group, in which, when the number of carbon atoms is at least 2, there are optionally 1 or 2 non-adjacent double bonds; 1 to 3 non-adjacent methylene groups are optionally replaced by NR 1 (where R 1 is H, alkyl, or acyl), O, or S; and 1 or 2 methylene groups are optionally replaced by a carbonyl or hydroxymethylene group for the preparation of a medicament or a pharmaceutical for the treatment of inflammatory diseases.

  使用含有化合物的组合物：其中R是C1-C10烷基基团，当碳原子数至少为2时，可以选则1或2个非相邻的双键；1到3个非相邻的亚甲基团可以被NR1（其中R1为H，烷基或酰基）、O或S替换；并且1或2个亚甲基团可以被羰基或羟甲基基团替换，以制备用于治疗炎症性疾病的药物或制剂。
• Compounds, Compositions and Methods for the Treatment of Amyloid Diseases and Synucleinopathies such as Alzheimer's Disease, Type 2 Diabetes and Parkinson's Disease
  申请人：SNOW Alan D.

  公开号：US20110172239A1

  公开（公告）日：2011-07-14

  Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.

  双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药学上可接受的酯，它们的合成，含有它们的制药组合物，以及它们在治疗淀粉样疾病，特别是阿尔茨海默病中观察到的Aβ淀粉样蛋白病，IAPP淀粉样蛋白病，如在2型糖尿病中观察到的和突触核蛋白病，如在帕金森病中观察到的用途，以及制造此类治疗药物。